An international eDelphi process led to the development of a treat-to-target framework for managing moderate-to-severe atopic dermatitis in adults. A steering committee established recommendations across three key areas, targeting specific improvements at 3 and 6 months. These recommendations achieved consensus on 16 core points. This framework aids in shared decision-making for systemic treatment strategies in atopic dermatitis.

Reference: De Bruin-Weller M, Biedermann T, Bissonnette R, et al. Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies. Acta Derm Venereol. 2021;101(2):adv00402. doi:10.2340/00015555-3751